Financial results - LAUR-PHARM SRL

Financial Summary - Laur-Pharm Srl
Unique identification code: 11974110
Registration number: J1999000165037
Nace: 4773
Sales - Ron
916.252
Net Profit - Ron
91.793
Employees
7
Open Account
Company Laur-Pharm Srl with Fiscal Code 11974110 recorded a turnover of 2024 of 916.252, with a net profit of 91.793 and having an average number of employees of 7. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Laur-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 290.897 269.358 308.001 343.133 362.397 383.563 514.774 689.472 759.711 916.252
Total Income - EUR 290.900 269.360 309.286 345.942 362.444 391.107 514.799 689.477 763.816 916.262
Total Expenses - EUR 289.974 256.800 295.280 329.283 346.403 365.863 468.613 599.312 686.135 808.614
Gross Profit/Loss - EUR 926 12.560 14.006 16.659 16.041 25.244 46.186 90.166 77.681 107.648
Net Profit/Loss - EUR 10 10.782 9.723 13.356 12.442 21.504 41.316 83.755 67.010 91.793
Employees 5 4 3 4 4 0 6 5 7 7
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 21.3%, from 759.711 euro in the year 2023, to 916.252 euro in 2024. The Net Profit increased by 25.157 euro, from 67.010 euro in 2023, to 91.793 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Laur-Pharm Srl

Rating financiar

Financial Rating -
LAUR-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Laur-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Laur-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Laur-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Laur-Pharm Srl - CUI 11974110

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 30.604 28.215 25.984 22.922 19.943 59.491 56.156 54.452 52.534 60.709
Current Assets 99.425 85.712 101.000 110.463 113.402 124.121 272.969 320.262 394.873 542.377
Inventories 59.917 53.351 52.401 49.787 60.088 71.932 147.957 194.650 198.430 207.200
Receivables 28.684 10.674 40.151 52.912 42.614 48.667 88.604 102.085 108.031 109.830
Cash 10.825 21.687 8.448 7.764 10.700 3.521 36.408 23.527 88.412 225.346
Shareholders Funds 11.456 20.996 19.810 23.257 22.152 15.821 56.786 97.931 164.644 255.517
Social Capital 45 45 44 43 42 45 44 45 44 44
Debts 118.574 92.930 107.174 110.128 111.193 167.791 272.339 276.783 282.762 347.569
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 542.377 euro in 2024 which includes Inventories of 207.200 euro, Receivables of 109.830 euro and cash availability of 225.346 euro.
The company's Equity was valued at 255.517 euro, while total Liabilities amounted to 347.569 euro. Equity increased by 91.793 euro, from 164.644 euro in 2023, to 255.517 in 2024.

Risk Reports Prices

Reviews - Laur-Pharm Srl

Comments - Laur-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.